Fresenius Medical Care AG & Co. (FMS)
(Delayed Data from NYSE)
$20.21 USD
-0.55 (-2.65%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $20.22 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum A VGM
Fresenius (FMS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$17.30 | $21.00 | $15.00 | -16.67% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Fresenius comes to $17.30. The forecasts range from a low of $15.00 to a high of $21.00. The average price target represents a decline of 16.67% from the last closing price of $20.76.
Analyst Price Targets (3 )
Broker Rating
Fresenius currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 2.82 a month ago based on 11 recommendations.
Of the 10 recommendations deriving the current ABR, two are Strong Buy, representing 20% of all recommendations. A month ago, Strong Buy represented 27.27%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 3.00 | 2.82 | 2.82 | 2.82 | 2.82 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/20/2024 | Truist Securities | David S Macdonald | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 2.82 |
# of Recs in ABR | 10 |
Average Target Price | $17.30 |
LT Growth Rate | 12.10% |
Industry | Medical - Instruments |
Industry Rank by ABR | 87 of 252 |
Current Quarter EPS Est: | 0.26 |